Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination

Clinical trial NCT07133802 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07133802
Sponsor: Changchun BCHT Biotechnology Co.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Prevention of Influenza

Start date: 2025-08-01
Primary completion: 2026-03-01
Enrollment: 6680

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.